Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.54 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.53 |
| ▸ | TLR2 | O60603 | 1/20 | 0.52 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.49 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.48 |
| ▸ | GLP1R | P43220 | 8/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.47 |
| ▸ | NMT2 | O60551 | 1/20 | 0.43 |
| ▸ | NMT1 | P30419 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20542799 | 0.89 | TLR2 (0.62) | LPAR3LPAR1TLR2SIRT6SIRT1 | |
| SCHEMBL10246707 | 0.86 | NOD1 (0.54) | LPAR3LPAR1TLR2NOD1 | |
| SCHEMBL10246700 | 0.83 | NOD1 (0.52) | TLR2NOD1 | |
| SCHEMBL20542804 | 0.83 | LPAR3 (0.65) | LPAR3LPAR1TLR2SIRT6SIRT1 | |
| SCHEMBL20542805 | 0.83 | LPAR3 (0.65) | LPAR3LPAR1TLR2SIRT6SIRT1 | |
| SCHEMBL25457033 | 0.81 | SIRT6 (0.69) | LPAR3LPAR1TLR2SIRT6SIRT1 | |
| SCHEMBL20543154 | 0.81 | SIRT6 (0.69) | LPAR3LPAR1TLR2SIRT6SIRT1 | |
| SCHEMBL17749154 | 0.81 | SIRT6 (0.69) | LPAR3LPAR1TLR2SIRT6SIRT1 | |
| SCHEMBL20543155 | 0.81 | SIRT6 (0.69) | LPAR3LPAR1TLR2SIRT6SIRT1 | |
| SCHEMBL17751797 | 0.81 | SIRT6 (0.69) | LPAR3LPAR1TLR2SIRT6SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3744729-B1 | PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | SEDERMA SA (FR) | 2023-03-01 | — | — | EP | disclosed |
| EP-3744729-A1 | COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | SEDERMA (FR) | 2020-12-02 | — | — | EP | disclosed |
| EP-2382230-B1 | PEPTIDES KXK, COMPOSITIONS LES COMPRENANT ET UTILISATIONS COSMETIQUES ET DERMO-PHARMACEUTIQUES. | SEDERMA SA (FR) | 2018-05-23 | — | — | EP | disclosed |
| US-8697656-B2 | Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses | SEDERMA (FR) | 2014-04-15 | — | — | US | disclosed |
| US-8697656-B2 | Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses | SEDERMA (FR) | 2014-04-15 | — | — | US | disclosed |
| US-20120014887-A1 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES | SEDERMA (FR) | 2012-01-19 | — | — | US | disclosed |
| US-20120014887-A1 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES | SEDERMA (FR) | 2012-01-19 | — | — | US | disclosed |
| WO-2010082177-A2 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | SEDERMA (FR) | 2010-07-22 | — | — | WO | disclosed |
| WO-2010082175-A2 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | SEDERMA (FR) | 2010-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120014887-A1 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES | CUTA, PLOD3, MC1R | LPAR3 586/4885LPAR1 819/4885TLR2 1036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.